Vitamin Shoppe Inc (VSI) reported quarterly earnings results on Wednesday, May-4-2016. The company said it had a profit of $0.67 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $0.65. The company posted revenue of $336.80 million in the period, compared to analysts expectations of $339.76 million. During the same quarter in the previous year, the company posted $0.63 EPS.
Many Wall Street Analysts have commented on Vitamin Shoppe Inc. Wedbush Initiated Vitamin Shoppe Inc on Apr 21, 2016 to “Outperform”, Price Target of the shares are set at $39.
Vitamin Shoppe Inc opened for trading at $27.87 and hit $28.54 on the upside on Monday, eventually ending the session at $28.39, with a gain of 3.73% or 1.02 points. The heightened volatility saw the trading volume jump to 5,81,187 shares. Company has a market cap of $732 M.
In a different news, on Aug 18, 2015, B. Michael Becker (director) sold 845 shares at $36.74 per share price. According to the SEC, on May 26, 2015, Colin Frederick Watts (CEO) purchased 2,400 shares at $41.02 per share price.
Vitamin Shoppe Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins minerals herbs specialty supplements sports nutrition and other health and wellness products (VMS). The Company operates through three segments: retail which includes Vitamin Shoppe Super Supplements and Vitapath retail store formats; direct which consists of its e-commerce and catalog formats and manufacturing which consists of the Nutri-Force manufacturing operations. The Company operates through its wholly owned subsidiary Vitamin Shoppe Industries Inc. and Vitamin Shoppe Industries Inc.s’ wholly owned subsidiaries VS Direct Inc. Vitamin Shoppe Mariner Inc. (VSM) VS Hercules LLC (VSH) Vitamin Shoppe Global Inc. (VSG) and Vitapath Canada Limited (VCL).